Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?
作者信息
Nielsen Suzanne, Larney Sarah
机构信息
Monash Addiction Research Centre, Monash University, Melbourne, Australia.
Centre de Recherche du CHUM and Department of Family Medicine and Emergency Medicine, University of Montreal, Montreal, Canada.
出版信息
Addiction. 2023 Jan;118(1):108-109. doi: 10.1111/add.16032. Epub 2022 Aug 31.
Abstract
摘要
相似文献
1
Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?关于格兰兹等人的评论：丁丙诺啡治疗时间延长与阿片类药物过量使用率降低有关，但我们能否解决维持治疗的障碍？
Addiction. 2023 Jan;118(1):108-109. doi: 10.1111/add.16032. Epub 2022 Aug 31.
2
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.美沙酮减量治疗后阿片类药物过量相关的处方特征。
JAMA Netw Open. 2022 Sep 1;5(9):e2234168. doi: 10.1001/jamanetworkopen.2022.34168.
3
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.将阿片类使用障碍治疗纳入监狱：延长释放丁丙诺啡在监禁环境中的潜力。
J Addict Med. 2022;16(4):396-398. doi: 10.1097/ADM.0000000000000942. Epub 2021 Dec 23.
4
Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths.佛蒙特州伯灵顿市和宾夕法尼亚州费城将被挪用的丁丙诺啡合法化：一项减少阿片类药物过量致死的干预措施。
J Law Med Ethics. 2020 Jun;48(2):373-375. doi: 10.1177/1073110520935353.
5
The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment.丁丙诺啡治疗持续时间与死亡率之间的关联：一项多地点队列研究中停止治疗的人群。
Addiction. 2023 Jan;118(1):97-107. doi: 10.1111/add.15998. Epub 2022 Jul 23.
6
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.在安大略省，使用美沙酮和丁丙诺啡治疗阿片类药物使用障碍的患者的使用时间和结局：一项基于人群的倾向评分匹配队列研究。
Addiction. 2022 Jul;117(7):1972-1981. doi: 10.1111/add.15862. Epub 2022 Mar 21.
7
Commentary on Burns et al. (2015): retention in buprenorphine treatment.对伯恩斯等人（2015年）的评论：丁丙诺啡治疗的留存率
Addiction. 2015 Apr;110(4):656-7. doi: 10.1111/add.12865.
8
Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.ED 患者中阿片类药物过量的药物治疗药物使用障碍的既往使用情况：流行率、误用和过量严重程度。
Am J Emerg Med. 2022 Jan;51:114-118. doi: 10.1016/j.ajem.2021.10.012. Epub 2021 Oct 12.
9
Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment.对考辛斯等人（2016年）的评论：关于阿片类药物替代治疗期间及停药后死亡风险的证据不断积累。
Addiction. 2016 Jan;111(1):83-4. doi: 10.1111/add.13185.
10
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.法律授权紧急医疗服务机构增加美沙酮治疗阿片类药物使用障碍的机会。
Ann Emerg Med. 2021 Jul;78(1):102-108. doi: 10.1016/j.annemergmed.2021.01.017. Epub 2021 Mar 27.
本文引用的文献
1
The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment.丁丙诺啡治疗持续时间与死亡率之间的关联：一项多地点队列研究中停止治疗的人群。
Addiction. 2023 Jan;118(1):97-107. doi: 10.1111/add.15998. Epub 2022 Jul 23.
2
Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients.调查阿片类激动剂治疗中患者剂量费用的成本和影响：对澳大利亚治疗患者的横断面调查结果。
Drug Alcohol Rev. 2022 May;41(4):841-850. doi: 10.1111/dar.13437. Epub 2022 Feb 7.
3
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.污名对阿片类药物使用障碍患者、阿片类药物治疗及政策的影响
Subst Abuse Rehabil. 2022 Jan 25;13:1-12. doi: 10.2147/SAR.S304566. eCollection 2022.
4
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.阿片类药物激动剂治疗者自付费用的经济分析：澳大利亚三个司法管辖区的横断面调查。
Int J Drug Policy. 2022 Jan;99:103472. doi: 10.1016/j.drugpo.2021.103472. Epub 2021 Oct 11.
5
Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia.追踪长效注射型丁丙诺啡的使用效益：澳大利亚患者体验的定性研究。
Drug Alcohol Depend. 2021 Oct 1;227:108959. doi: 10.1016/j.drugalcdep.2021.108959. Epub 2021 Aug 11.
6
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.阿片类药物替代治疗期间及之后的死亡风险：队列研究的系统评价和荟萃分析
BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.
7
Clear rhetoric and blurred reality: the development of a recovery focus in UK drug treatment policy and practice.清晰的言辞与模糊的现实：英国药物治疗政策与实践中康复导向的发展
Int J Drug Policy. 2014 Sep;25(5):957-63. doi: 10.1016/j.drugpo.2014.01.014. Epub 2014 Jan 31.
Zotero 插件